Insider · CIK 0001225767

WADE JEFFREY L

Reports to the SEC for 1 company · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001225767

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	President and COO	AAward	+307K sh	—	—	307,000
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+11.2K sh	—	—	275,518
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+37.3K sh	—	—	312,792
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+49.1K sh	—	—	361,905
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−37.7K sh	$2.62	−$98.8K	324,214
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−11.2K sh	—	—	0
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−37.3K sh	—	—	37,273
2024-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−49.1K sh	—	—	98,227
2024-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	President and COO	AAward	+314K sh	—	—	314,320
2024-02-08	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	President and COO	AAward	+314K sh	—	—	314,320
2023-09-14	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	President and COO	PPurchase	+10K sh	$1.38	+$13.8K	264,341
2023-06-20	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	President and COO	PPurchase	+10K sh	$2.33	+$23.4K	252,341
2023-06-20	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	President and COO	PPurchase	+2,000 sh	$2.33	+$4,650	254,341
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+30.5K sh	—	—	224,147
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+11.2K sh	—	—	235,323
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+37.3K sh	—	—	272,596
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−30.3K sh	$2.17	−$65.7K	242,341
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−30.5K sh	—	—	0
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−11.2K sh	—	—	11,177
2023-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−37.3K sh	—	—	74,547
2023-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	President and COO	AAward	+147K sh	—	—	147,340
2023-02-09	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	President and COO	AAward	+442K sh	—	—	442,030
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+25.3K sh	—	—	177,810
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+30.5K sh	—	—	208,276
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+11.2K sh	—	—	219,453
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−25.8K sh	$2.85	−$73.5K	193,680
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−25.3K sh	—	—	0
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−30.5K sh	—	—	30,467
2022-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−11.2K sh	—	—	22,353
2022-02-10	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	President and COO	AAward	+335K sh	—	—	335,470
2022-02-10	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	President and COO	AAward	+112K sh	—	—	111,820
2021-04-14	LXRXLEXICON PHARMACEUTICALS, INC.G Gift	President and COO	GGift	−4,500 sh	—	—	152,520
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+2,797 sh	—	—	118,292
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+9,555 sh	—	—	127,847
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+25.3K sh	—	—	153,137
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+30.5K sh	—	—	183,604
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−26.6K sh	$7.19	−$191K	157,020
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−2,797 sh	—	—	0
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−9,555 sh	—	—	0
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−25.3K sh	—	—	25,290
2021-02-28	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	President and COO	MExercise/Conversion	−30.5K sh	—	—	60,933
2021-02-11	LXRXLEXICON PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	President and COO	AAward	+33.5K sh	—	—	33,530
2021-02-11	LXRXLEXICON PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	President and COO	AAward	+101K sh	—	—	100,600
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.A Award	President and COO	AAward	+26.5K sh	—	—	125,146
2020-04-22	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−9,651 sh	$1.96	−$18.9K	115,495
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+4,495 sh	—	—	77,003
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+2,798 sh	—	—	79,801
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+9,555 sh	—	—	89,356
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+25.3K sh	—	—	114,646
2020-02-28	LXRXLEXICON PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−16K sh	$2.77	−$44.4K	98,621

Recent filings

Accepted (ET)
Jul 84
WADE JEFFREY L0001127602-24-020203
SEC(opens sec.gov)
Feb 294
WADE JEFFREY L0001127602-24-007628
SEC(opens sec.gov)
Feb 124
WADE JEFFREY L0001127602-24-004470
SEC(opens sec.gov)
Sep 144
WADE JEFFREY L0001127602-23-024201
SEC(opens sec.gov)
Jun 204
WADE JEFFREY L0001127602-23-018978
SEC(opens sec.gov)
Mar 14
WADE JEFFREY L0001127602-23-007917
SEC(opens sec.gov)

Companies

LEXICON PHARMACEUTICALS, INC.President and COOLXRX

Address

8800 TECHNOLOGY FOREST PLACE

THE WOODLANDS, TX, 773811160